[Liver surgery for colorectal liver metastases]

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Colorectal liver metastases (CLM) are a common challenge in oncology.
• Surgical resection is the only potentially curative treatment for CLM.
• Current five-year survival rates after resection range from 40-50%, with only 30% of patients eligible for surgery.

Purpose of the Study:

• To review current liver surgery options for CLM.
• To identify strategies for enhancing resectability in initially non-resectable CLM.
• To discuss predictive factors influencing surgical outcomes.

Main Methods:

• Literature review and analysis of long-term clinical experience.
• Discussion of perioperative oncological treatments.
• Exploration of advanced surgical techniques and palliative interventions.

Main Results:

• Liver surgery remains the primary treatment modality for CLM.
• Multidisciplinary team approach and optimized diagnostic/treatment strategies can overcome limitations.
• Predictive factors and thorough follow-up are crucial for successful outcomes.

Conclusions:

• Optimizing treatment strategies through multidisciplinary collaboration is key to improving CLM management.
• Advanced surgical techniques and tailored perioperative care can expand treatment options.
• Continuous evaluation of predictive factors and patient follow-up enhance long-term results.